Cetera Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Buy
+11,227
New +$198K ﹤0.01% 4399
2024
Q4
Sell
-171,428
Closed -$2.59M 3829
2024
Q3
$2.59M Buy
171,428
+15,044
+10% +$228K 0.01% 1427
2024
Q2
$2.22M Buy
156,384
+10,137
+7% +$137K 0.01% 1486
2024
Q1
$1.99M Buy
146,247
+10,979
+8% +$152K ﹤0.01% 1546
2023
Q4
$1.82M Buy
135,268
+18,268
+16% +$225K 0.01% 836
2023
Q3
$1.46M Buy
117,000
+11,107
+10% +$146K 0.01% 882
2023
Q2
$1.43M Buy
105,893
+13,093
+14% +$181K 0.01% 918
2023
Q1
$1.29M Buy
92,800
+13,123
+16% +$188K 0.01% 924
2022
Q4
$1.13M Buy
79,677
+13,915
+21% +$202K 0.01% 942
2022
Q3
$898K Buy
65,762
+6,907
+12% +$103K 0.02% 765
2022
Q2
$838K Buy
58,855
+11,527
+24% +$174K 0.01% 865
2022
Q1
$783K Sell
47,328
-630
-1% -$10.8K 0.01% 906
2021
Q4
$922K Sell
47,958
-71,259
-60% -$1.43M 0.01% 839
2021
Q3
$2.48M Sell
119,217
-15,960
-12% -$342K 0.04% 448
2021
Q2
$2.9M Buy
135,177
+3,623
+3% +$73.1K 0.05% 410
2021
Q1
$2.59M Buy
131,554
+35,957
+38% +$741K 0.05% 362
2020
Q4
$1.89M Buy
+95,597
New +$1.77M 0.04% 446

Other funds holding HQL

Cetera Investment Advisers's HQL Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 11,227 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #4399 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in HQL as recently as Q3 2024.

Cetera Investment Advisers first reported a position in HQL in Q4 2020 and has held it in 17 quarters since. The position peaked at $2.9M in Q2 2021. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Cetera Investment Advisers held 11,227 shares of abrdn Life Sciences Investors worth $225K as of Q2 2026.
  • abrdn Life Sciences Investors was a new Cetera Investment Advisers position in Q2 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4399 holding.
  • Cetera Investment Advisers first reported a position in abrdn Life Sciences Investors in Q4 2020 and has held it in 17 quarters since.
  • Cetera Investment Advisers's abrdn Life Sciences Investors position peaked at $2.9M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.